In utero gene transfer of human factor IX to fetal mice can induce postnatal tolerance of the exogenous clotting factor

Abstract excerpt

The fundamental hypotheses behind fetal gene therapy are that it may be possible (1) to achieve immune tolerance of transgene product and, perhaps, vector; (2) to target cells and tissues that are inaccessible in adult life; (3) to transduce a high percentage of rapidly proliferating cells, and in particular stem cells, with relatively low absolute virus doses leading to clonal transgene amplification by...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to CAR-T cell therapy research
• Share to Parvovirus B19 Infection Studies
• Share to Virus-based gene therapy research